However, evidence suggests that PD-L1 binding to PD-1 may induce tumor cell resistance to chemotherapy, enhanced glycolytic metabolism, and greater migration and invasion capacities in the absence of T cells [2, 31, 97]. This evidence concerns the gene CD274 and neoplasm.